Physician

Stephen Meffert, M.D.

According to 2025 Medicare claims, Stephen Meffert, M.D. (NPI: 1609879105) practices ophthalmology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. Meffert uses personal NPI as billing NPI and primary practice location at 95403-3612.

Meffert's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 863 traditional Medicare patients, billed 52,422 HCPCS/CPT codes, and received $3,666,643 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 473 prescription claims across 138 beneficiaries totaling $19,364 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 2 records totaling $126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $45,225 to $19,364. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.7M2015 Medicare payment: $2,713,780 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,849,753 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,964,645 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,235,417 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,664,016 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,338,619 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,584,513 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,411,277 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,423,656 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,666,643 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201583912,068$2,713,780
201684712,947$2,849,753
201786912,822$2,964,645
201886212,991$3,235,417
201989312,318$3,664,016
202078611,000$3,338,619
202177511,536$3,584,513
202280314,439$3,411,277
202380428,262$3,423,656
202486352,422$3,666,643

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$25K$50K2015 Drug cost: $45,225 (USD; Tot_Drug_Cst)2016 Drug cost: $49,646 (USD; Tot_Drug_Cst)2017 Drug cost: $46,977 (USD; Tot_Drug_Cst)2018 Drug cost: $41,251 (USD; Tot_Drug_Cst)2019 Drug cost: $38,140 (USD; Tot_Drug_Cst)2020 Drug cost: $36,643 (USD; Tot_Drug_Cst)2021 Drug cost: $43,654 (USD; Tot_Drug_Cst)2022 Drug cost: $27,622 (USD; Tot_Drug_Cst)2023 Drug cost: $28,255 (USD; Tot_Drug_Cst)2024 Drug cost: $19,364 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015120412$45,225
2016127475$49,646
2017141451$46,977
2018137454$41,251
2019127425$38,140
2020104373$36,643
2021131460$43,654
2022102376$27,622
2023124460$28,255
2024138473$19,364

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2232,066$650
67028Injection of drug into eye3701,692$110
92014Established patient complete exam of visual system463522$103
92134Imaging of retina8562,533$34
92202Extended exam of the back part of the eye with optic nerve drawing151151$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1496,045$5,647
Bromfenac SodiumBromfenac Sodium11454$2,817
Ketorolac TromethamineKetorolac Tromethamine753,392$1,997
Atropine SulfateAtropine Sulfate754,378$1,805
DifluprednateDifluprednate12780$1,255

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$126Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Stephen Meffert, M.D.?

Tedicare shows public-source Medicare data for Stephen Meffert, M.D. (NPI 1609879105), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen Meffert, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephen Meffert, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Stephen Meffert, M.D. have Open Payments data?

Stephen Meffert, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.